4-butyrolactone has been researched along with Arthritis, Rheumatoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiao, HB; Hsieh, CC; Lin, H; Lin, WC; Wu, JB | 1 |
| Choi, H; Choi, HG; Kim, E; Kim, GJ; Kim, SH; Kim, SY; Lee, JY; Nam, JW; Shim, SH | 1 |
| Imai, H; Kurimoto, Y; Morita, S; Naiki, M; Suehiro, S; Taguchi, N; Takeoka, Y | 1 |
3 other study(ies) available for 4-butyrolactone and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen Type II; Cytokines; Disease Models, Animal; Edema; Inflammation Mediators; Knee Joint; Male; Mice, Inbred DBA; Monosaccharides; Orchidaceae; Phytotherapy; Plant Extracts; T-Lymphocytes | 2016 |
Cinnamomulactone, a new butyrolactone from the twigs of Cinnamomum cassia and its inhibitory activity of matrix metalloproteinases.
Topics: 4-Butyrolactone; Arthritis, Rheumatoid; Cell Survival; Cinnamomum; Dexamethasone; Fibroblasts; Humans; Interleukin-1beta; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Plant Extracts; Plant Stems; Spectrophotometry, Ultraviolet; Tumor Necrosis Factor-alpha | 2017 |
2-Buten-4-olide (2-B4O) inhibits type II collagen-induced arthritis in Lewis rats.
Topics: 4-Butyrolactone; Animals; Antibody Formation; Arthritis, Rheumatoid; Arthrography; Collagen; Disease Models, Animal; Female; Furans; Hypersensitivity, Delayed; Rats; Rats, Inbred Lew | 1993 |